Pieris Pharmaceuticals, Inc. (PIRS): Price and Financial Metrics

Pieris Pharmaceuticals, Inc. (PIRS): $16.01

0.42 (+2.69%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add PIRS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#116 of 332

in industry

PIRS Price/Volume Stats

Current price $16.01 52-week high $22.32
Prev. close $15.59 52-week low $6.20
Day low $15.59 Volume 8,000
Day high $16.25 Avg. volume 47,792
50-day MA $16.55 Dividend yield N/A
200-day MA $13.80 Market Cap 21.13M

PIRS Stock Price Chart Interactive Chart >


Pieris Pharmaceuticals, Inc. (PIRS) Company Bio


Pieris Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers and develops Anticalin-based drugs. The company develops Anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids. The company is based in Boston, Massachusetts.


PIRS Latest News Stream


Event/Time News Detail
Loading, please wait...

PIRS Latest Social Stream


Loading social stream, please wait...

View Full PIRS Social Stream

PIRS Price Returns

1-mo -2.52%
3-mo -11.40%
6-mo 52.77%
1-year -1.90%
3-year -94.35%
5-year -94.47%
YTD 9.96%
2023 -82.50%
2022 -72.49%
2021 51.20%
2020 -30.94%
2019 36.09%

Continue Researching PIRS

Want to see what other sources are saying about Pieris Pharmaceuticals Inc's financials and stock price? Try the links below:

Pieris Pharmaceuticals Inc (PIRS) Stock Price | Nasdaq
Pieris Pharmaceuticals Inc (PIRS) Stock Quote, History and News - Yahoo Finance
Pieris Pharmaceuticals Inc (PIRS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!